Liao Xing, Xie Yan-ming, Wang Yong-yan, Nicola Robinson
Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(24):4723-7.
There has been much difference between effectiveness and harm in evidence evaluation. Many evidence ranking or grading systems have been developed'by researchers in the world. However, no evidence ranking or grading systems are based on safety research reality. Those existing evidence ranking or grading systems are prone to evaluating effectiveness evidence not proper for harm evidence. It is necessary to develop a new system for harm evidence. We put forward to establishing the body of evidence for harm for postmarketing traditional Chinese medicine as required by our daily research work. We do hope such an ideal could be helpful and indicative for evidence evaluation for harm.
在证据评估中,有效性与危害之间存在很大差异。世界上的研究人员已经开发了许多证据排名或分级系统。然而,没有证据排名或分级系统是基于安全性研究实际情况的。那些现有的证据排名或分级系统倾向于评估适用于有效性证据而非危害证据。有必要开发一种针对危害证据的新系统。根据我们日常研究工作的要求,我们提出建立上市后中药危害证据体系。我们确实希望这样一种设想能够对危害证据评估有所帮助并具有指导意义。